Lilly slips on outlook
This article was originally published in Scrip
Executive Summary
Lilly's share price was trading down by 1% at $69.03 in mid-afternoon trading on 7 January after the company released a financial update that fell below analysts' expectations for 2015 and included a downgrade for its 2014 earnings.